Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Report 2026

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays market size has reached to $1.57 billion in 2025 • Expected to grow to $3.83 billion in 2030 at a compound annual growth rate (CAGR) of 19.5% • Growth Driver: Rising Adoption Of Personalized Medicine Driving The Market Growth Due To Targeted Genetic Detection And Tailored Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market?

Clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays are molecular diagnostic tools that use CRISPR-Cas systems combined with fluorescent reporters to detect specific DNA or RNA sequences. They are used to enable rapid, sensitive, and precise detection of pathogens, genetic mutations, or biomarkers. These assays offer high specificity due to CRISPR-guided targeting and real-time visualization through fluorescence signals. The main product types of clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays include kits, reagents, instruments, and other product types. Kits refer to ready-to-use assemblies containing all necessary materials to perform CRISPR-based fluorescence detection experiments. They are provided in Cas9-based fluorescence assays, Cas12-based fluorescence assays, Cas13-based assays, and other technologies and come in fluorescence-based and lateral flow detection methods. They find application in gene editing, diagnostics, drug discovery, and other applications, serving end users including academic and research institutes, pharmaceutical and biotechnology companies, clinical laboratories, and other end-users.

What Is The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Growth Forecast?

The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market size is expected to see rapid growth in the next few years. It will grow to $3.83 billion in 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to growing adoption of multiplex and high-throughput assays, increasing integration with ai-enabled analysis platforms, rising demand for point-of-care diagnostics, expansion of clinical laboratory capabilities, increasing focus on personalized medicine applications. Major trends in the forecast period include increasing adoption of multiplex crispr fluorescence assays, rising demand for cas12 and cas13-based detection technologies, growing integration of real-time fluorescence readers, expansion of diagnostic and drug discovery applications, rising focus on high-sensitivity pathogen and biomarker detection.

Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Segmentation

1) By Product Type: Kits, Reagents, Instruments, Other Product Types 2) By Technology: Cas9-Based Fluorescence Assays, Cas12-Based Fluorescence Assays, Cas13-Based Assays, Other Technologies 3) By Detection: Fluorescence-Based, Lateral Flow 4) By Application: Gene Editing, Diagnostics, Drug Discovery, Other Applications 5) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users Subsegments: 1) By Kits: Detection Kits, Editing Kits, Multiplex Kits 2) By Reagents: Cas Enzymes, Buffers And Solutions, Probes And Reporters 3) By Instruments: Fluorescence Readers, Real-Time PCR Instruments, Microplate Readers 4) By Other Product Types: Consumables, Accessories, Software

What Are The Drivers Of The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market?

The rising preference for personalized medicine is expected to propel the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market going forward. Personalized medicine refers to tailoring medical treatment and prevention to an individual’s genetic, environmental, and lifestyle characteristics for optimal effectiveness. The growth of personalized medicine is driven by the rising prevalence of chronic diseases, which require targeted therapies that are more effective for individual patients than standard treatments. CRISPR fluorescence assays help personalized medicine by enabling rapid, highly specific detection of genetic mutations or biomarkers in a patient’s DNA, allowing doctors to identify disease-causing variants and tailor treatments based on the individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the rising preference for personalized medicine is driving the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays industry. The rising research and development activities are expected to propel the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market going forward. Research and development (R&D) activities involve creating and testing new knowledge, products, or processes to drive innovation and business growth. Research and development activities are increasing as companies seek to drive growth and stay ahead by creating new and improved products or technologies. Research and development activities support CRISPR fluorescence assays by advancing assay technologies, improving detection precision, and creating novel solutions for genetic analysis and targeted therapies. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 billion ($22.1 billion) in 2023, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise. Therefore, the rising research and development activities are driving the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays industry.

Key Players In The Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

Major companies operating in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market are Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Bio‑Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Ginkgo Bioworks, OriGene Technologies Inc., Synthego Corporation, Inscripta Inc., Mammoth Biosciences Inc., Creative Biolabs, Cellecta Inc., GeneCopoeia Inc., SBS Genetech Co. Ltd., Addgene, CrisprBits Private Limited.

What Are Latest Mergers And Acquisitions In The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market?

In December 2024, OraSure Technologies Inc., a US-based medical device company, acquired Sherlock Biosciences Inc. for an undisclosed amount. With this acquisition, OraSure aims to expand its infectious disease testing portfolio by incorporating Sherlock’s CRISPR-Cas13 diagnostic platforms and fluorescence-based CRISPR detection technology to accelerate next-generation molecular diagnostics. Sherlock Biosciences Inc. is a US-based biotechnology company that offers CRISPR-based diagnostic assays that utilize fluorescence detection.

Regional Insights

North America was the largest region in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market?

The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market includes revenues earned by entities providing services such as pathogen detection, genetic mutation screening, and gene expression analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market includes sales of CRISPR-based detection kits, reagents, Cas enzymes, fluorescent reporters, and assay consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Report 2026?

The clustered regularly interspaced short palindromic repeats (crispr) fluorescence assays market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clustered regularly interspaced short palindromic repeats (crispr) fluorescence assays industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.